AP3225A - New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it - Google Patents

New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it

Info

Publication number: AP3225A
Authority: AP; ARIPO
Prior art keywords: hexahydrocyclopenta; pyrrol; benzamide; propoxy; cis
Prior art date: 2011-12-09

Application number

AP2012006607A

Other languages

English (en)

Other versions

AP2012006607A0 (en

Inventor

Caryn Trocme-Thibierge

Aurore Sors

Annette Merdes

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-12-09

Filing date

2012-12-05

Publication date

2015-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47682151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3225(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-12-05 Application filed by Servier Lab filed Critical Servier Lab

2012-12-31 Publication of AP2012006607A0 publication Critical patent/AP2012006607A0/xx

2015-04-30 Application granted granted Critical

2015-04-30 Publication of AP3225A publication Critical patent/AP3225A/xx

Links

MRNMYWNBLVJWKG-GASCZTMLSA-N 4-[3-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]propoxy]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1OCCCN1C[C@H]2CCC[C@H]2C1 MRNMYWNBLVJWKG-GASCZTMLSA-N 0.000 title 1
229940099433 NMDA receptor antagonist Drugs 0.000 title 1
239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AP2012006607A 2011-12-09 2012-12-05 New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it AP3225A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1103777A FR2983732B1 (fr)	2011-12-09	2011-12-09	Nouvelle association entre le 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}pharmaceutiques qui la contiennent

Publications (2)

Publication Number	Publication Date
AP2012006607A0 AP2012006607A0 (en)	2012-12-31
AP3225A true AP3225A (en)	2015-04-30

Family

ID=47682151

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2012006607A AP3225A (en)	2011-12-09	2012-12-05	New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it

Country Status (28)

Country	Link
US (2)	US8921409B2 (es)
EP (1)	EP2601942A1 (es)
JP (1)	JP5591310B2 (es)
KR (1)	KR101489670B1 (es)
CN (1)	CN103157111B (es)
AP (1)	AP3225A (es)
AR (1)	AR089112A1 (es)
AU (1)	AU2012258339A1 (es)
BR (1)	BR102012031031A2 (es)
CA (1)	CA2798549A1 (es)
CL (1)	CL2012003437A1 (es)
CO (2)	CO6660080A1 (es)
CR (1)	CR20120608A (es)
EA (1)	EA201201530A1 (es)
EC (1)	ECSP12012329A (es)
FR (1)	FR2983732B1 (es)
GT (1)	GT201200329A (es)
MA (1)	MA34867B1 (es)
MD (1)	MD4348B1 (es)
MX (1)	MX2012014184A (es)
NI (1)	NI201200178A (es)
PE (1)	PE20130813A1 (es)
PH (1)	PH12012000378A1 (es)
SG (1)	SG191494A1 (es)
TN (1)	TN2012000563A1 (es)
TW (1)	TWI457123B (es)
UY (1)	UY34475A (es)
WO (1)	WO2013083887A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR3003466B1 (fr) *	2013-03-22	2015-08-07	Servier Lab	Utilisation du 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide pour le traitement des douleurs neuropathiques
KR101484405B1 (ko) *	2013-08-14	2015-01-19	서울대학교산학협력단	Ｎｉｎｊｕｒｉｎ１ 결핍 유래의 강박증 예방 또는 치료용 약학적 조성물
GB201509134D0 (en) *	2015-05-28	2015-07-15	Electrophoretics Ltd	Biomolecules involved in Alzheimer's disease
HK1247847A1 (zh)	2015-07-22	2018-10-05	阿纳韦克斯生命科学公司	四氢-N，N-二甲基-2，2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1509232E (pt) *	2002-05-31	2009-01-07	Lundbeck & Co As H	Uma combinação de um antagonista de nmda e inibidores da acetilcolina esterase para o tratamento da doença de alzheimer
EP2260844A1 (en) *	2003-05-27	2010-12-15	Merz Pharma GmbH & Co. KGaA	Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders
EP1638560A1 (en) *	2003-06-20	2006-03-29	Eli Lilly And Company	3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
WO2005067908A2 (en) *	2004-01-05	2005-07-28	Merz Pharma Gmbh & Co. Kgaa	Memantine for the treatment of mild and mild-to-moderate alzheimer’s disease
FR2866647B1 (fr) *	2004-02-20	2006-10-27	Servier Lab	Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TW200531680A (en) *	2004-03-03	2005-10-01	Merz Pharma Gmbh & Co Kgaa	Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease
JP2007529556A (ja) *	2004-03-19	2007-10-25	アクソニクスインコーポレイテッド	認知障害の処置に有用なアセチルコリンエステラーゼ阻害剤およびｎ−メチル−ｄ−アスパラギン酸拮抗剤
FR2937119B1 (fr)	2008-10-15	2010-12-17	Air Liquide	Procede de production d'energie et capture de co2
FR2937251B1 (fr) *	2008-10-16	2011-03-18	Servier Lab	Utilisation du 4-{3-°hexahydrocyclopenta°c!pyrrol-2(1h)-yl! propoxy}benzamide pour l'obtention de medicaments destines au traitement des troubles du sommeil
FR2953515B1 (fr) *	2009-12-09	2011-12-23	Servier Lab	Nouveaux derives du type hexahydrocyclopenta[b]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2011
- 2011-12-09 FR FR1103777A patent/FR2983732B1/fr not_active Expired - Fee Related
2012
- 2012-04-27 CO CO12069442A patent/CO6660080A1/es unknown
- 2012-11-28 PE PE2012002234A patent/PE20130813A1/es not_active Application Discontinuation
- 2012-11-28 UY UY0001034475A patent/UY34475A/es unknown
- 2012-11-28 PH PH1/2012/000378A patent/PH12012000378A1/en unknown
- 2012-11-28 AU AU2012258339A patent/AU2012258339A1/en not_active Abandoned
- 2012-11-29 TN TNP2012000563A patent/TN2012000563A1/fr unknown
- 2012-11-29 SG SG2012087771A patent/SG191494A1/en unknown
- 2012-12-03 CR CR20120608A patent/CR20120608A/es unknown
- 2012-12-03 MD MDA20120119A patent/MD4348B1/ro not_active IP Right Cessation
- 2012-12-03 NI NI201200178A patent/NI201200178A/es unknown
- 2012-12-03 MA MA35425A patent/MA34867B1/fr unknown
- 2012-12-05 AP AP2012006607A patent/AP3225A/xx active
- 2012-12-05 BR BR102012031031-7A patent/BR102012031031A2/pt not_active Application Discontinuation
- 2012-12-05 MX MX2012014184A patent/MX2012014184A/es not_active Application Discontinuation
- 2012-12-06 KR KR20120141338A patent/KR101489670B1/ko not_active Expired - Fee Related
- 2012-12-06 CA CA2798549A patent/CA2798549A1/fr not_active Abandoned
- 2012-12-06 TW TW101145875A patent/TWI457123B/zh not_active IP Right Cessation
- 2012-12-06 CL CL2012003437A patent/CL2012003437A1/es unknown
- 2012-12-06 JP JP2012267342A patent/JP5591310B2/ja not_active Expired - Fee Related
- 2012-12-06 CO CO12221472A patent/CO6690116A1/es unknown
- 2012-12-06 US US13/706,828 patent/US8921409B2/en not_active Expired - Fee Related
- 2012-12-07 GT GT201200329A patent/GT201200329A/es unknown
- 2012-12-07 EA EA201201530A patent/EA201201530A1/ru unknown
- 2012-12-07 EP EP12195997.7A patent/EP2601942A1/fr not_active Withdrawn
- 2012-12-07 EC ECSP12012329 patent/ECSP12012329A/es unknown
- 2012-12-07 AR ARP120104595A patent/AR089112A1/es unknown
- 2012-12-07 WO PCT/FR2012/000505 patent/WO2013083887A1/fr not_active Ceased
- 2012-12-10 CN CN201210530112.9A patent/CN103157111B/zh not_active Expired - Fee Related
2014
- 2014-11-25 US US14/553,206 patent/US20150080448A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR102012031031A2 (pt)	2013-10-29
ECSP12012329A (es)	2013-01-31
NI201200178A (es)	2013-05-13
FR2983732B1 (fr)	2013-11-22
WO2013083887A1 (fr)	2013-06-13
WO2013083887A8 (fr)	2013-08-08
CN103157111A (zh)	2013-06-19
GT201200329A (es)	2014-03-14
US8921409B2 (en)	2014-12-30
US20130150421A1 (en)	2013-06-13
EP2601942A1 (fr)	2013-06-12
MA34867B1 (fr)	2014-02-01
CA2798549A1 (fr)	2013-06-09
EA201201530A1 (ru)	2013-07-30
FR2983732A1 (fr)	2013-06-14
KR101489670B1 (ko)	2015-02-04
US20150080448A1 (en)	2015-03-19
CR20120608A (es)	2014-03-05
AU2012258339A1 (en)	2013-06-27
JP2013121956A (ja)	2013-06-20
MX2012014184A (es)	2013-06-18
MD4348B1 (ro)	2015-05-31
TW201334777A (zh)	2013-09-01
CO6690116A1 (es)	2013-06-17
TWI457123B (zh)	2014-10-21
UY34475A (es)	2013-07-31
CO6660080A1 (es)	2013-04-30
CN103157111B (zh)	2015-02-11
KR20130065602A (ko)	2013-06-19
CL2012003437A1 (es)	2014-01-24
PH12012000378A1 (en)	2015-09-11
AP2012006607A0 (en)	2012-12-31
NZ604084A (en)	2014-07-25
AR089112A1 (es)	2014-07-30
JP5591310B2 (ja)	2014-09-17
PE20130813A1 (es)	2013-07-28
SG191494A1 (en)	2013-07-31
TN2012000563A1 (fr)	2014-04-01

Publication	Publication Date	Title
IL228506A (en)	2016-11-30	Opioid receptor ligands and pharmacy preparations containing them
AP3104A (en)	2015-01-31	New association between 4-{3-[CIS-hexahydrocyclopenta[c]pyrrol-2(1H)-YL]propoxy}benzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
SG11201404030YA (en)	2014-10-30	P2x4 receptor antagonist
IL225550A0 (en)	2013-06-27	4cxcr receptor antagonists
LT2552920T (lt)	2017-06-12	Nauji nk-3 receptoriaus selektyvūs antagonistų junginiai, farmacinė kompozicija ir būdai, skirti naudoti nk-3 receptoriaus sąlygotų sutrikimų gydymui
SG2014011555A (en)	2014-08-28	Lysophosphatidic acid receptor antagonists
IL230218A (en)	2016-12-29	Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
ZA201207292B (en)	2014-03-26	Cgrp receptor antagonist
PT2785692T (pt)	2018-01-04	Anilinas substituídas como antagonistas do ccr(4)
ZA201306744B (en)	2014-11-26	Antagonists of the interleukin-1 receptor
ZA201305576B (en)	2014-10-29	Trpm8 receptor antagonists
PT2935227T (pt)	2017-12-06	Amidas diazol como antagonistas do recetor ccr1
ZA201405959B (en)	2016-08-31	Novel neurokinin 1 receptor antagonist compounds
EP2617717A4 (en)	2014-01-01	ANTAGONIST OF P2X4 RECEIVER
AP3225A (en)	2015-04-30	New combination between 4-{3-[CIS-hexahydrocyclopenta[C]pyrrol-2(1H)-yl]propoxy}benzamide and an NMDA receptor antagonist, and pharmaceutical compositions containing it
ZA201403245B (en)	2015-06-24	Process for the preparation of an endothelin receptor antagonist
ZA201204183B (en)	2013-02-27	Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride and pharmaceutical compositions containing it
AP2014008141A0 (en)	2014-12-31	N-[4-(quinolin-4-yloxy) cyclohexyl (methyl)](hetero) arylcarboxamides as androgen receptor antagonist, production and use thereof as medicinal products
IL241743A0 (en)	2015-11-30	Non-competitive nicotinic receptor antagonists
IL237150B (en)	2018-07-31	Preparations containing combinations of receptor antagonists and agonists
ZA201303872B (en)	2014-08-27	Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
FR2976286B1 (fr)	2013-05-24	4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent
AU2012202328A1 (en)	2012-11-22	New Association Between 4-{3-[cis-Hexahydrocyclopenta[c]pyrrol-2(1H)-yl]-propoxy}Benzamide and an Acetylcholinesterase inhibitor, and Pharmaceutical Compositions Containing It
IL230334A0 (en)	2014-03-06	Non-competitive nicotinic receptor antagonists
HK1187526A (en)	2014-04-11	Lysophosphatidic acid receptor antagonists and uses thereof